Takeda Pharmaceutical Co Ltd - Insider Trading & Ownership

Location
1 1, Nihonbashi Honcho 2 Chome, Chuo Ku, Tokyo, Japan
Summary
The estimated value of insider holdings of Takeda Pharmaceutical Co Ltd is at least $124M dollars as of September 19, 2025. Takeda Pharmaceutical Co Ltd is the 10%+ Owner of Day One Biopharmaceuticals, Inc. and owns shares of Day One Biopharmaceuticals, Inc. (DAWN) stock worth about $71.5M. Takeda Pharmaceutical Co Ltd is the 10%+ Owner of Phathom Pharmaceuticals, Inc. and owns shares of Phathom Pharmaceuticals, Inc. (PHAT) stock worth about $30.4M. Takeda Pharmaceutical Co Ltd is the 10%+ Owner of Ovid Therapeutics Inc. and owns shares of Ovid Therapeutics Inc. (OVID) stock worth about $16.2M. Takeda Pharmaceutical Co Ltd is the 10%+ Owner of Theseus Pharmaceuticals, Inc. and owns shares of Theseus Pharmaceuticals, Inc. stock worth about $4.93M. Takeda Pharmaceutical Co Ltd is the 10%+ Owner of Xilio Therapeutics, Inc. and owns shares of Xilio Therapeutics, Inc. (XLO) stock worth about $1.22M.
Signature
/s/ Paul Sundberg, Authorized Signatory, Takeda Pharmaceutical Company Limited
All Insider Reports
All Insider Reports

Ownership of Takeda Pharmaceutical Co Ltd

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
DAWN Day One Biopharmaceuticals, Inc. 10%+ Owner $71.5M Dec 7, 2021
PHAT Phathom Pharmaceuticals, Inc. 10%+ Owner $30.4M Jan 24, 2024
OVID Ovid Therapeutics Inc. 10%+ Owner $16.2M Jul 1, 2022
THRX Theseus Pharmaceuticals, Inc. 10%+ Owner $4.93M Oct 12, 2021
XLO Xilio Therapeutics, Inc. 10%+ Owner $1.22M Oct 26, 2021
HLVX HilleVax, Inc. 10%+ Owner $0 Sep 17, 2025
CALA Calithera Biosciences, Inc. Former 10% Owner Apr 17, 2023

Insider Transactions Reported by Takeda Pharmaceutical Co Ltd:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.